Public spirometry for primary prevention of COPD

Journal of Evaluation in Clinical Practice

Volumn 20, Issue 1, 2014, Pages 43-47

  Zirlik, Sabine ^a   Wich, Christina ^a   Frieser, Markus ^a   Hildner, Kai ^a   Kleye, Christin ^a   Neurath, Markus F ^a   Fuchs, Florian S ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

COPD; FEV1; primary prevention; public spirometry; quit smoking; tabacco smoke

Indexed keywords

ADULT; AGE DISTRIBUTION; AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOTIVATION; PRIMARY PREVENTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEX RATIO; SMOKING CESSATION; SMOKING HABIT; SPIROMETRY; YOUNG ADULT;

COPD; FEV1; PRIMARY PREVENTION; PUBLIC SPIROMETRY; QUIT SMOKING; TABACCO SMOKE;

ADULT; AGE FACTORS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTIVATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX FACTORS; SMOKING; SMOKING CESSATION; SPIROMETRY;

EID: 84892578900     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/jep.12077     Document Type: Article

References (12)

1. Buist, A. S., McBurnie, M. A., Vollmer, W. M., et al. (2007) International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet, 370, 741-750.
2. Global strategy for diagnosis, management, and prevention of COPD Update 2009. Available at: http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2= 1&intId=2180.
3. Anthonisen, N. R., Skeans, M. A., Wise, R. A., Manfreda, J., Kanner, R. E., &, Connett, J. E., (2005) The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Annals of Internal Medicine, 142, 233-239.
4. Anthonisen, N. R., Connett, J. E., Kiley, J. P., et al. (1994) Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA: the Journal of the American Medical Association, 272, 1497-1505.
5. Lin, K., Watkins, B., Johnson, T., Rodriguez, J. A., &, Barton, M. B., (2008) Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 148, 535-543.
6. Bednarek, M., Gorecka, D., Wielgomas, J., et al. (2006) Smokers with airway obstruction are more likely to quit smoking. Thorax, 61, 869-873.
7. Parkes, G., Greenhalgh, T., Griffin, M., &, Dent, R., (2008) Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ (Clinical Research Ed.), 336, 598-600.
8. Mahler, D. A., &, Wells, C. K., (1988) Evaluation of clinical methods for rating dyspnea. Chest, 93, 580-586.
9. Miller, M. R., Hankinson, J., Brusasco, V., et al. (2005) Standardisation of spirometry. The European Respiratory Journal, 26, 319-338.
10. Quanjer, P. H., Tammeling, G. J., Cotes, J. E., Pedersen, O. F., Peslin, R., &, Yernault, J. C., (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. The European Respiratory Journal. Supplement, 16, 5-40.
11. Federal Statistical Office (2007) Chapter 9: Public Health. Statistical Yearbook 2007. Reutlingen: SFG Servicecenter Fachverlage. p. 241.
12. Hansen, J. E., Sun, X. G., &, Wasserman, K., (2007) Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not <70%. Chest, 131, 349-355.